Knight Disposes of a Toddler-Sized Amount of Pediapharm Inc.

Author's Avatar
Aug 31, 2018
Article's Main Image

MONTREAL, Aug. 31, 2018 (GLOBE NEWSWIRE) -- This press release is being disseminated by Knight Therapeutics Inc. ("Knight") (TSX:GUD, Financial), a specialty pharmaceutical company, as required by National Instrument 62-103 - The Early Warning System and Related Take Over Bid and Insider Reporting Issues regarding the disposition of securities of Pediapharm Inc. ("Pediapharm").